Awsare, Ninaad S., Martin, Tracey Amanda ORCID: https://orcid.org/0000-0003-2690-4908, Haynes, Mark D., Matthews, Philip N. and Jiang, Wen Guo ORCID: https://orcid.org/0000-0002-3283-1111 2011. Claudin-11 decreases the invasiveness of bladder cancer cells. Oncology Reports 25 (6) , pp. 1503-1509. 10.3892/or.2011.1244 |
Preview |
PDF
- Published Version
Download (1MB) | Preview |
Abstract
The expression of claudin-11 in benign and malignant bladder tissue and the effect of forced expression of claudin-11 on tight junction function and invasiveness of bladder cancer cells were studied. Claudin-11 expression was tested in bladder cancer cell lines (T24/83, RT 112/84 and EJ138) using reverse transcription-polymerase chain reaction (RT-PCR) and in benign and malignant bladder tissue by quantitative RT-PCR and immunohistochemistry. T24/83 cells were transfected with the pcDNA.1/NT-GFP-TOPO vector containing full-length human claudin-11 sequence. Stable-transfected cells overexpressing claudin-11 (T24Cl-11Ex), wild-type cells (T24WT) and the empty plasmid control clone (T24GFP) were compared using transurothelial resistance (TUR), in vitro adhesion, invasion and growth assays. Claudin-11 was strongly expressed in the non-invasive RT112/84 cell line compared to the invasive T24/83 and EJ138 TCC cell lines. Benign bladder tissue demonstrated equal expression of claudin-11 mRNA as carcinoma, but displayed more intense staining than malignant tissue on immunohistochemistry. Forced-expression of claudin-11 in T24/83 cells was confirmed by PCR, immunoprecipitation and by immunofluorescence, which demonstrated increased perinuclear claudin-11 staining. Forced expression of claudin-11 did not affect TUR (p=0.243), but significantly reduced invasion (p=0.001) while increasing cell matrix adhesion (p=0.001) and growth rates (p=0.001). The greater expression of claudin-11 in benign vs. malignant tissue and non-invasive vs. invasive cell lines, and its effect in reducing bladder cancer cell invasiveness suggests that claudin-11 may have a role in preventing cancer progression and may serve as a therapeutic target in reducing metastasis.
Item Type: | Article |
---|---|
Date Type: | Publication |
Status: | Published |
Schools: | Medicine |
Subjects: | R Medicine > RC Internal medicine > RC0254 Neoplasms. Tumors. Oncology (including Cancer) |
Additional Information: | Pdf uploaded in accordance with publisher's policy at http://www.sherpa.ac.uk/romeo/issn/1021-335X/ (accessed 20/02/2014). |
Publisher: | Spandidos |
ISSN: | 1021-335X |
Date of First Compliant Deposit: | 30 March 2016 |
Last Modified: | 10 May 2023 19:31 |
URI: | https://orca.cardiff.ac.uk/id/eprint/29578 |
Citation Data
Cited 19 times in Scopus. View in Scopus. Powered By Scopus® Data
Actions (repository staff only)
Edit Item |